Drugs

What is Symtuza?

Symtuza is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults who have never taken HIV medicines before. The FDA has also approved Symtuza for use in adults who meet certain requirements, as determined by a health care provider.

Symtuza is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines.

• Darunavir – an HIV medicine called a protease inhibitor (PI)
• Cobicistat – a medicine called a pharmacokinetic enhancer, which is used to increase the effectiveness of darunavir 
• Emtricitabine – an HIV medicine called a nucleoside reverse transcriptase inhibitor (NRTI)
• Tenofovir alafenamide – another HIV medicine (also an NRTI) 

PIs block an HIV enzyme called protease. NRTIs block an HIV enzyme called reverse transcriptase. By blocking these enzymes, the drugs in Symtuza prevent HIV from multiplying and can reduce the amount of HIV in the body.

HIV medicines can’t cure HIV/AIDS, but taking a combination of HIV medicines (called an HIV treatment regimen) every day helps people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission. If you are taking HIV medicines, including Symtuza, don’t cut down on, skip, or stop taking them unless your health care provider tells you to.

What should I tell my health care provider before taking Symtuza?

Before taking Symtuza, tell your health care provider:

• If you are allergic to any of the HIV medicines in Symtuza (darunavir, cobicistat, emtricitabine, or tenofovir alafenamide) or any other medicines.
• If you have liver problems, including hepatitis B virus infection (HBV) or hepatitis C virus infection (HCV).
• If you have kidney problems.
• If you are allergic to sulfa (sulfonamide).
• If you have diabetes.
• If you have hemophilia.
• If you have any other medical conditions.
• If you are pregnant or plan to become pregnant. Talk to your health care provider about the risks and benefits of taking Symtuza during pregnancy.
• If you are breastfeeding or plan to breastfeed. Do not breastfeed if you have HIV or are taking Symtuza.
• If you are using hormone-based birth control (such as pills, implants, or vaginal rings). Symtuza may make these forms of birth control less effective. Your health care provider can help you decide how to adjust your birth control while you are taking Symtuza. For more information about using birth control and HIV medicines at the same time, view the AIDSinfo HIV and Birth Control infographic.
• About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products (particularly St. John’s wort) you are taking or plan to take. Symtuza may affect the way other medicines or products work, and other medicines or products may affect how Symtuza works. Taking Symtuza together with certain medicines or products may cause serious side effects.

How should I take Symtuza?

Symtuza comes in tablet form. Each tablet contains:

• 800 mg darunavir (brand name: Prezista)
• 150 mg cobicistat (brand name: Tybost)
• 200 mg emtricitabine (brand name: Emtriva)
• 10 mg tenofovir alafenamide

Take Symtuza according to your health care provider’s instructions.

Do not change your dose or stop taking Symtuza without talking to your health care provider.

Take Symtuza once a day with food.

If you have difficulty swallowing, the tablet may be split using a tablet cutter. After splitting the tablet, the entire dose (both halves) should be taken right away.

If you take too much Symtuza, contact your health care provider or local poison control center (1-800-222-1222) right away, or go to the nearest hospital emergency room.

For more information on how to take Symtuza, see the FDA drug label.

What should I do if I forget a dose?

If you miss a dose of Symtuza, take the missed dose as soon as you remember it. But if it is almost time for your next dose, skip the missed dose and just take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

What side effects can Symtuza cause?

Symtuza may cause side effects. Many side effects from HIV medicines, such as nausea or occasional dizziness, are manageable. See the AIDSinfo fact sheet on HIV Medicines and Side Effects for more information.

Some side effects of Symtuza can be serious. Serious side effects of Symtuza include severe or life-threatening skin reactions or rash, a buildup of lactic acid in the blood (lactic acidosis), and severe liver problems (See section above: What are the most important things to know about Symtuza?).

• Changes in your immune system (called immune reconstitution inflammatory syndrome or IRIS). IRIS is a condition that sometimes occurs when the immune system begins to recover after treatment with an HIV medicine. As the immune system gets stronger, it may have an increased response to a previously hidden infection.
• New or worse kidney problems, including kidney failure.
• Diabetes and high blood sugar (hyperglycemia).
• Changes in body fat (including gain or loss of fat).
• Increased bleeding for hemophiliacs.

Tell your health care provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Symtuza. To learn more about possible side effects of Symtuza, read the drug label or package insert or talk to your health care provider or pharmacist.

You can report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088) or online.

How should Symtuza be stored?

• Store Symtuza at room temperature, 68°F to 77°F (20°C to 25°C).
• Keep Symtuza in the container that it came in and keep the container tightly closed. If the container has a small packet of drying agent (called a desiccant), do not remove it. The desiccant protects the medicine from moisture.
• Do not use Symtuza if the original seal over the container opening is broken or missing.
• Throw away Symtuza that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
• Keep Symtuza and all medicines out of reach of children.

Where can I find more information about Symtuza?

More information about Symtuza is available:

• The Symtuza drug label. The Patient Counseling Information section of the label includes information for people taking Symtuza.
• Symtuza-related research studies, from the AIDSinfo database of ClinicalTrials.gov study summaries.
• A list of FDA-approved HIV medicines, from AIDSinfo.